Skip to content

Reducing adverse electroconvulsive treatment effects on memory by magnetic stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN05721091
Enrollment
80
Registered
2006-06-07
Start date
2006-04-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Memory impairment Signs and Symptoms Memory impairment

Interventions

1. Randomisation to either ECT or MST groups 2. ECT protocol (treatment as usual): ECT will be administered in line with the latest guidelines from the Royal College of Psychiatrists. Seizure threshol
pulse width 1 ms
MECTA Spectrum™ 5000 M), and monitored by electroencephalogram (EEG). The clinical team responsible for the patient will determine the need for and duration of treatment, usually between 6 and 12 trea

Sponsors

University of Edinburgh (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Referred to and accepted by ECT service for treatment of major depressive episode 2. Able to give informed consent to ECT and to trial procedure 3. If patient is detained, ECT would be given with patient's consent (valid T2 form completed)

Exclusion criteria

Exclusion criteria: 1. Contraindications for ECT or anaesthesia 2. Unable or unwilling to give informed consent to ECT or to trial procedure 3. Patients with organic diagnoses (e.g. dementia, schizophrenia and substance abuse) 4. Patients with metallic implants or pacemakers 5. Pregnancy 6. Aged <18 years

Design outcomes

Secondary

MeasureTime frame
Not provided at time of registration

Primary

MeasureTime frame
Last follow-up six months after course of treatment of last recruited subject recruited before 31st March 2008 or 80th subject recruited

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026